Trials / Unknown
UnknownNCT03316612
The Effect of Vaccinium Myrtillus L. Extract Intake on Human Metabolism
The Effect of Vaccinium Myrtillus L. Extract Intake on Human Metabolism: A Randomized Double-Blind Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Huazhong University of Science and Technology · Academic / Other
- Sex
- All
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
Advanced glycation end-products (AGEs) has been linked to ageing, and many metabolic diseases. The findings of previous experiments suggested that the extracts from polyphenol-rich bilberry might inhibit the formation of AGEs. This is a randomized double-blind trial, aims to study the effect of Vaccinium Myrtillus L. natural extracts on AGEs and human metabolism. Firstly, we will investigate the efficacy of Bilberry extracts on lowering the levels of advanced glycation end-products (AGEs). Secondly, we will conduct 16S rRNA sequencing and ultra-high performance liquid chromatography-tandem mass spectrometric (UPLC-MS/MS) detection to explore the role of bilberry extracts on gut microbiota as well as metabolites.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Vaccinium Myrtillus L. extract | Twice a day, 2 tablets each time. Do not take any other medicine, traditional Chinese medicine, or dietary supplements. |
| DIETARY_SUPPLEMENT | Placebo | Twice a day, 2 tablets each time. Do not take any other medicine, traditional Chinese medicine, or dietary supplements. |
Timeline
- Start date
- 2017-11-10
- Primary completion
- 2018-06-30
- Completion
- 2018-10-30
- First posted
- 2017-10-20
- Last updated
- 2018-04-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03316612. Inclusion in this directory is not an endorsement.